Skip to main content
. 2015 Jan 27;9(4):1927–1933. doi: 10.3892/ol.2015.2910

Figure 3.

Figure 3

Kaplan-Meier analysis of disease-free and overall survival rates in 196 non-small cell lung cancer (NSCLC) patients in relation to IMP3 protein expression. (A) NSCLC patients with insulin-like growth factor II mRNA binding protein 3 (IMP3)-positive expression exhibited a lower disease-free survival rate compared with those without IMP3 expression. (B) NSCLC patients with IMP3-positive expression exhibited a lower overall survival rate compared with those without IMP3 expression.